Michael Becker submits:
The 2010 BMT Tandem Meetings were held in Orlando, Florida this past week [February 24-28, 2010]. Considered the premier event for hematopoietic cell transplantation [HCT] and cellular therapy, the annual event attracts more than 2,500 clinicians, transplant nurses, clinical research professionals, data managers, pharmacists, center administrators and mid-level practitioners.
With more than 200 abstracts being presented on the topic, the meeting provided an opportunity to validate some of the conclusions from our recent “Graft Versus Host Disease: Failures and Future Opportunities” article. In particular, we reviewed data presented during the meeting and interviewed several experts in the area of Graft-versus-Host disease [GvHD] to reconfirm our three key findings: